comparemela.com

Page 9 - Cann Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Synlait [ASX:SM1] and A2 [ASX:A2M] Baby Formula Products Officially Approved by New Chinese Standard

Synlait and The a2 Milk Company received approval from Chinese authorities for the re-registration of their Chinese label of infant milk formula which is now to be manufactured in line with the country’s regulations, removing any pre-existing anxiety over the issue.

Raiz Invest [ASX:RZI] Shares May s Snapshot of Active Customers and Funds

Fintech Raiz Invest says that despite some continuing market volatility shaking general markets lately, it still managed to reach $1.139.34 million in global FUM for the month ending 31 May.

Infratil [ASX:IFT] Announces NZ$850 Million Equity Raise for One NZ Acquisition

Infratil raises AU$774 million to help fund the acquisition of a 49.9% stake in One NZ, taking its ownership to 9.90%.

Medical Group Polynovo [ASX:PNV] Hits New Record for Monthly Sales

Medical researcher Polynovo posted a record monthly sale total of $7.2 million in the month of May, led by $5.2 million in the United States with new records also hitting in Canada, Hong Kong, India, and a new order in the Middle East. The group’s total revenue for the 11 months to May rose 54%.

Starpharma s [ASX:SPL] Viraleze Nasal Spray Receives Approval in Malaysia

Biotech Starpharma has received regulatory approval for its Viraleze product to be used in Malaysia, adding the product to a wider market base that now spans 35 countries as it looks into further COVID-19 studies in the UK.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.